17 October 2019: Articles
Spontaneous Fungal Peritonitis as a Rare Complication of Ascites Secondary to Cardiac Cirrhosis: A Case Report
Challenging differential diagnosis, Rare disease
Dharti Patel ABDEF 1, Arshad Muhammad Iqbal ABCDEF 1*, Ateeq Mubarik DEF 1, Fahad Zafar EF 1, Salaah M. Siddiqui E 1, Aamani Jupalli F 1, Nikolay P. Mitzov AEF 1, Salman Muddassir ADF 1DOI: 10.12659/AJCR.917757
Am J Case Rep 2019; 20:1526-1529
Abstract
BACKGROUND: Spontaneous fungal peritonitis (SFP) is a life-threatening infection which occurs more commonly in patients with liver failure. SFP is not as common as spontaneous bacterial peritonitis (SBP) and has higher mortality rates due to late recognition and difficulty in differentiation between SFP and SBP. Spontaneous fungal peritonitis is extremely uncommon in patients with cardiac ascites due to a high protein content, which predisposes to a low risk of infections.
CASE REPORT: This report presents a rare case of spontaneous fungal peritonitis in a patient with cardiogenic ascites. To the best of our knowledge, this is the second known case of SFP occurring in a patient with cardiac cirrhosis. The patient did not respond to initiation of SBP treatment and after ascitic fluid grew Candida glabrata, the diagnosis of SFP was made. The patient’s clinical status improved after initiation of intravenous caspofungin.
CONCLUSIONS: SFP should be a differential diagnosis in patients who have cardiac or liver cirrhosis, who are not improving with empirical antibiotic therapy for spontaneous bacterial peritonitis.
Keywords: Ascites, Candida glabrata, peritonitis, Antifungal Agents, caspofungin, Diagnosis, Differential, Fibrosis, Mycoses, Time Factors
Background
Spontaneous fungal peritonitis (SFP) is an infection defined as a neutrophil count (>250 cells/mL) in ascitic fluid with the evidence of a positive fungal culture [1], while excluding other intra-abdominal infections. SFP is not as common as spontaneous bacterial peritonitis and has a mortality rate due to late recognition and difficulty in differentiation between SFP and systolic blood pressure (SBP) [1,2]. The common risk factors that have been shown to increase the mortality of SFP include hepatorenal syndrome, patient on SBP prophylaxis, high APACHE II scores on admission, increased lactate levels, history of alcoholic cirrhosis, and an elevated Model for End-Stage Liver Disease (MELD) score [2,3]. In the Candida species,
Case Report
This case is of a 52-year-old female with a past medical history of chronic obstructive pulmonary disease who was admitted to the hospital for a 2-week history of abdominal pain and shortness of breath. The abdominal pain was associated with worsening distension. On admission, she was febrile with Tmax of 38.3°C (101°F), tachycardic with a heart rate of 110 beats per minute, and blood pressure of 100/80 mmHg. Cardiovascular examination was positive for jugular venous distension. Respiratory examination revealed decreased breath sounds on bilateral lung bases. The abdomen was distended with diffuse abdominal tenderness, flank fullness, an everted umbilicus, and fluid thrill palpable diffusely. Initial laboratory assessment showed normal white blood cell (WBC) count of 7900/mm3, absolute neutrophil count (ANC) of 6936/mm3, hemoglobin 15.8 g/dL, hematocrit 60.3, mean corpuscular volume (MCV) 66.5, platelet count 406×103/mm3, blood urea nitrogen 10 mg/dL, creatinine 0.9 mg/dL, total bilirubin 3.40 mg/dL with direct bilirubin of 2.30 mg/dL, aspartate aminotransferase (AST) 43 U/L, alanine aminotransferase 28 U/L, lipase of 43 U/L, ammonia of 51, pro-BNP (B-type natriuretic peptide) of 4447, and initial albumin of 4.5 g/dL. Other chemistries included sodium of 120 mmol/L, potassium of 4.9 mmol/L, chloride of 84 mmol/L, and bicarbonate of 33 mmol/L. Arterial blood gas on admission showed a pH of 7.33 with pCO2 58.7 mmHg, PO2 75, and bicarbonate of 30 mmol/L on FiO2 of 100%. Hepatitis A, B, and C panel and human immunodeficiency virus (HIV) were nonreactive. Autoimmune workup including ANA and anti-smooth muscle antibodies were also negative. Initial imaging of the chest x-ray showed only a right-sided pleural effusion, but computed tomography (CT) of the abdomen and pelvis showed bilateral pleural effusions with consolidation on the right, moderate ascites, and liver cirrhosis with no focal lesion (Figure 1). An echocardiogram showed normal left ventricular ejection fraction of 55%, dilated right ventricle, moderate tricuspid regurgitation with right ventricular systolic pressure of 76 mmHg suggesting severe pulmonary hypertension.
A diagnostic and therapeutic ultrasound guided paracentesis was done on admission and 400 mL of yellow fluid was removed and sent for analysis and cultures. The patient was empirically started on ceftriaxone for possible spontaneous bacterial peritonitis. On Day 3, the patient was not able to maintain saturation above 70% on room air after high flow oxygen via venti mask and non-rebreather and had increased respirations of more than 35 breaths per minute; the decision was made to intubate. Antibiotics were also changed to vancomycin and piperacillin-tazobactam. The ascitic fluid analysis showed hazy fluid with a specific gravity 1.023 with a WBC count of 23 000 mm3, with 92% of polymorphic cells and 8% of mononuclear cells, ascitic albumin of 3.1 g/dL, with a serum ascites albumin gradient (SAAG) of 1.4 g/dL. On Day 5, her repeat complete blood count (CBC) showed an elevated WBC count of 14.5/mm3, with the absolute neutrophil count of 12 180/mm3. Preliminary cultures from the ascitic fluid grew yeast and the diagnosis of spontaneous fungal peritonitis was made and started on intravenous caspofungin. Two sets of blood cultures were negative. The patient responded gradually to antifungals and was extubated on Day 11. Speciation of fluid was reported on Day 10, which indicated
Discussion
Cardiac cirrhosis is a rare but well-documented disease characterized by the presence of signs and symptoms of chronic liver disease along with a history of cardiac failure [6,7]. Usually, it presents with sign and symptoms consistent with congestive heart failure along with clinical features of portal hypertension [8]. The basic pathophysiology includes hypoxic hepatitis due to impaired arterial perfusion (forward failure) and increased hepatic congestion (backward failure) [9]. This backward flow, which is most commonly seen in right heart failure, causes an increase in liver lymphatic production resulting in ascites [10].
Ascites due to heart failure is generally considered at low risk for infections because of the high protein content in the ascitic fluid. The high protein level is optimal for creating a bactericidal environment along with an intact reticuloendothelial system, which differs than SBP [11]. According to another theory, the gut hypothesis states that patients with heart failure will have increased congestion in the gut which leads to chronic intestinal damage, allowing bacteria to translocate to the ascitic fluid [12]. However, an acute episode of exacerbation may also cause further damage, leading to increase translocation of the fungal organism [12]. Ascitic fluid should be evaluated by laboratory testing and imaging. Ascitic fluid retrieved by diagnostic paracentesis should be analyzed for lactate dehydrogenase, cytology, total cell count and differential, total protein, albumin, and bacterial and fungal culture sensitivities [13]. Cell count and the differential is very important to make the diagnosis of spontaneous fungal peritonitis (polymorphonuclear neutrophils >250 cells/mL). Along with the bacterial Gram stain and culture sensitivity, fungal stain and culture sensitivities are necessary due to the rising prevalence of SFP in patients with cirrhosis [14].
The common fungi causing SFP are
Diagnosing SFP requires culture and sensitivity of the ascitic fluid, however, polymerase chain reaction and beta-D glucan can also be done if the clinical suspicion is high. These tests are faster than conventional culture and sensitivities tests [16,17]. Treatment with echinocandins is recommended as soon as the diagnosis is made. However, the prognosis is poor if there is a delay in appropriate antifungal therapy, especially with severe underlying disease [18]. As this is the second known case of SFP from cardiac cirrhosis, aggressive management was done immediately to salvage the patient and prompt for a quick recovery compared to the first diagnosed case of SFP with cardiogenic ascites. In the first diagnosed case, there was a delay in diagnosis from getting the speciation of cultures, versus in our case, immediate cultures including fungal cultures were taken to make a diagnosis of SFP with appropriate sensitivities. Karvellas et al. also reported that the delay in the diagnosis and treatment of SFP can lead to poor prognosis with a mortality of 100% [2]. De-escalation to systemic fluconazole is recommended when sensitivity tests are available, which is also beneficial in reducing the rise of resistant organisms [19].
Conclusions
To conclude, SFP is considered a serious complication of cardiac cirrhosis. A better understanding of the etiology of SFP with a quick diagnosis should be done promptly with an urgent evaluation of ascitic fluid and treatment with broad-spectrum antifungal therapy. There has been only one other successfully treated documented case of cardiac cirrhosis from SFP, hence this case provides additional literature on the importance of keeping SFP as a differential diagnosis in patients with cirrhosis (Table 1).
References:
1.. Hwang SY, Yu SJ, Lee J-H, Spontaneous fungal peritonitis: A severe complication in patients with advanced liver cirrhosis: Eur J Clin Microbiol Infect Dis, 2014; 33(2); 259-64, pmid: 23996048
2.. Karvellas CJ, Abraldes JG, Arabi YM, Kumar A, Cooperative antimicrobial therapy of septic shock (CATSS) database research group. Appropriate and timely antimicrobial therapy in cirrhotic patients with spontaneous bacterial peritonitis-associated septic shock: A retrospective cohort study: Aliment Pharmacol Ther, 2015; 41(8); 747-57, pmid: 25703246
3.. Hassan EA, Abd El-Rehim AS, Hassany SM, Fungal infection in patients with end-stage liver disease: Low frequency or low index of suspicion: Int J Infect Dis, 2014; 23; 69-74, pmid: 24726663
4.. Bremmer DN, Garavaglia JM, Shields RK, Spontaneous fungal peritonitis: A devastating complication of cirrhosis: Mycoses, 2015; 58(7); 387-93, pmid: 25851525
5.. Siddiqui S, Iqbal AM, Patel D, Spontaneous fungal peritonitis – a rare complication of ascites secondary to right heart failure: A case report: Amer J Gastroent, 2019; 114; S1249
6.. Blumgart HL, Katzin H, “Cardiac cirrhosis” of the liver: A clinical and pathological study”: Trans Am Clin Climatol Assoc, 1938; 54; 82-86, pmid: 21407567
7.. Sekiyama T, Nagano T, Aramaki T, Congestive (cardiac) cirrhosis: Nihon Rinsho, 1994; 52(1); 229-33
8.. Larry Jameson J, Fauci AS, Kasper DL, 2017; 5228, McGraw Hill Professional Available from:
9.. Birrer R, Takuda Y, Takara T, Hypoxic hepatopathy: pathophysiology and prognosis: Intern Med, 2007; 46(14); 1063-70, pmid: 17634701
10.. Cogger VC, Fraser R, Le Couteur DG, Liver dysfunction and heart failure: Am J Cardiol, 2003; 91; 1399, pmid: 12767448
11.. Wiest R, Krag A, Gerbes A, Spontaneous bacterial peritonitis: Recent guidelines and beyond: Gut, 2012; 61; 297-310, pmid: 22147550
12.. Thalheimer U, De Iorio F, Capra F, Altered intestinal function precedes the appearance of bacterial DNA in serum and ascites in patients with cirrhosis: A pilot study: Eur J Gastroenterol Hepatol, 2010; 22(10); 1228-34, pmid: 20512041
13.. Rogler G, Rosano G, The heart and the gut: Eur Heart J, 2014; 35(7); 426-30, pmid: 23864132
14.. Wiest R, Krag A, Gerbes A, Spontaneous bacterial peritonitis: Recent guidelines and beyond: Gut, 2012; 61(2); 297-310, pmid: 22147550
15.. Lahmer T, Brandl A, Rasch S, Fungal peritonitis: Underestimated disease in critically ill patients with liver cirrhosis and spontaneous peritonitis: PLoS One, 2016; 11(7); e0158389, pmid: 27390856
16.. Shi L, Wu D, Wei L, Corrigendum: Nosocomial and community-acquired spontaneous bacterial peritonitis in patients with liver cirrhosis in China: Comparative microbiology and therapeutic implications: Sci Rep, 2017; 7 46868
17.. Bucsics T, Schwabl P, Mandorfer M, Peck-Radosavljevic M, Prognosis of cirrhotic patients with fungiascites and spontaneous fungal peritonitis (SFP): J Hepatol, 2016; 64(6); 1452-54, pmid: 26916528
18.. Navasa M, Follo A, Llovet JM, Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis: Gastroenterology, 1996; 111(4); 1011-17, pmid: 8831596
19.. Sartelli M, Viale P, Koike K, WSES consensus conference: Guidelines for first-line management of intra-abdominal infections: World J Emerg Surg, 2011; 6; 2, pmid: 21232143
20.. Wang Y, Gandhi S, Attar BM, Spontaneous fungal peritonitis in ascites of cardiac origin: ACG Case Rep J, 2017; 4; e42, pmid: 28386572
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949976
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950290
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950607
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950985
Most Viewed Current Articles
07 Dec 2021 : Case report
17,691,734
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
164,491
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
113,090
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
59,175
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






